Title: J&J Innovative Medicine ADaM Test Data
Version: 0.0.1
Description: A set of Analysis Data Model (ADaM) datasets constructed by modifying the ADaM datasets in the 'pharmaverseadam' package to meet J&J Innovative Medicine's standard data structure for Clinical and Statistical Programming.
License: Apache License (≥ 2)
Encoding: UTF-8
LazyData: true
RoxygenNote: 7.3.2
Language: en-US
Depends: R (≥ 3.5), pharmaverseadam
NeedsCompilation: no
Packaged: 2025-07-10 16:20:07 UTC; DTord
Author: David Munoz Tord [aut, cre], Nicholas Masel [aut], Joe Kovach [aut], Mahesh Divakaran [ctb], J&J Innovative Medicine [cph, fnd]
Maintainer: David Munoz Tord <david.munoztord@mailbox.org>
Repository: CRAN
Date/Publication: 2025-07-15 11:40:08 UTC

pharmaverseadamjnj: J&J Innovative Medicine ADaM Test Data

Description

A set of Analysis Data Model (ADaM) datasets constructed by modifying the ADaM datasets in the 'pharmaverseadam' package to meet J&J Innovative Medicine's standard data structure for Clinical and Statistical Programming.

Author(s)

Maintainer: David Munoz Tord david.munoztord@mailbox.org

Authors:

Other contributors:


adae

Description

adae modified from pharmaverseadam

Usage

adae

Format

A data frame with 1191 rows and 78 variables:

DOMAIN

Domain Abbreviation

USUBJID

Unique Subject Identifier

AESEQ

Sequence Number

AESPID

Sponsor-Defined Identifier

AETERM

Reported Term for the Adverse Event

AELLT

Lowest Level Term

AELLTCD

Lowest Level Term Code

AEDECOD

Dictionary-Derived Term

AEPTCD

Preferred Term Code

AEHLT

High Level Term

AEHLTCD

High Level Term Code

AEHLGT

High Level Group Term

AEHLGTCD

High Level Group Term Code

AEBODSYS

Body System or Organ Class

AEBDSYCD

Body System or Organ Class Code

AESOC

Primary System Organ Class

AESOCCD

Primary System Organ Class Code

AESEV

Severity/Intensity

AESER

Serious Event

AEACN

Action Taken with Study Treatment

AEREL

Causality

AEOUT

Outcome of Adverse Event

AESCAN

Involves Cancer

AESCONG

Congenital Anomaly or Birth Defect

AESDISAB

Persist or Signif Disability/Incapacity

AESDTH

Results in Death

AESHOSP

Requires or Prolongs Hospitalization

AESLIFE

Is Life Threatening

AESOD

Occurred with Overdose

AEDTC

Date/Time of Collection

AESTDTC

Start Date/Time of Adverse Event

AEENDTC

End Date/Time of Adverse Event

AESTDY

Study Day of Start of Adverse Event

AEENDY

Study Day of End of Adverse Event

ASTDTM

Analysis Start Date/Time

ASTDTF

Analysis Start Date Imputation Flag

ASTTMF

Analysis Start Time Imputation Flag

AENDTM

Analysis End Date/Time

AENDTF

Analysis End Date Imputation Flag

AENTMF

Analysis End Time Imputation Flag

ASTDT

Analysis Start Date

AENDT

Analysis End Date

ASTDY

Analysis Start Relative Day

AENDY

Analysis End Relative Day

ADURN

Analysis Duration (N)

ADURU

Analysis Duration Units

LDOSEDTM

End Date/Time of Last Dose

ASEV

Analysis Severity/Intensity

AREL

Analysis Causality

TRTEMFL

Treatment Emergent Analysis Flag

ASEVN

Analysis Severity/Intensity (N)

AOCCIFL

1st Max Sev./Int. Occurrence Flag

AETOXGR

Standard Toxicity Grade

AETOXGRN

Standard Toxicity Grade (N)

AEACN_DECODE

Action Taken with Study Treatment

DOSEDY

Day of Study Drug

DOSEU

Treatment Dose Units

DOSEON

Treatment Dose at Record Start

AECONTRT

Concomitant or Additional Trtmnt Given

CQ01NAM

Customized Query 01 Name

CQ02NAM

Customized Query 02 Name

CQ03NAM

Customized Query 03 Name

AESMIE

Other Medically Important Serious Event

ACAT1

Analysis Category 1

AESER_DECODE

Serious Event

AEREL_DECODE

Causality

AEOUT_DECODE

Outcome of Adverse Event

AOCCFL

1st Occurance within Subject Flag

AOCCPFL

1st Occurance within Preferred Term Flag

AOCCSFL

1st Occurrence of SOC Flag

TRT01A

Actual Treatment for Period 01

SAFFL

Safety Population Flag

AGE

Age

SEX

Sex

RACE

Race

RACE_DECODE

Race

STUDYID

Study Identifier

AGEGR1

Pooled Age Group 1

Source

data from pharmaverseadam.

See Also

adae adaefmq adcm adeg adex adexsum adlb adsl adttesaf advs# nolint

Examples

 head(data("adae"))

adaefmq

Description

adae modified from pharmaverseadam to include FDA Medical Query information

Usage

adaefmq

Format

A data frame with 1979 rows and 81 variables:

DOMAIN

Domain Abbreviation

USUBJID

Unique Subject Identifier

AESEQ

Sequence Number

AESPID

Sponsor-Defined Identifier

AETERM

Reported Term for the Adverse Event

AELLT

Lowest Level Term

AELLTCD

Lowest Level Term Code

AEDECOD

AEDECOD

AEPTCD

Preferred Term Code

AEHLT

High Level Term

AEHLTCD

High Level Term Code

AEHLGT

High Level Group Term

AEHLGTCD

High Level Group Term Code

AEBODSYS

Body System or Organ Class

AEBDSYCD

Body System or Organ Class Code

AESOC

Primary System Organ Class

AESOCCD

Primary System Organ Class Code

AESEV

Severity/Intensity

AESER

Serious Event

AEACN

Action Taken with Study Treatment

AEREL

Causality

AEOUT

Outcome of Adverse Event

AESCAN

Involves Cancer

AESCONG

Congenital Anomaly or Birth Defect

AESDISAB

Persist or Signif Disability/Incapacity

AESDTH

Results in Death

AESHOSP

Requires or Prolongs Hospitalization

AESLIFE

Is Life Threatening

AESOD

Occurred with Overdose

AEDTC

Date/Time of Collection

AESTDTC

Start Date/Time of Adverse Event

AEENDTC

End Date/Time of Adverse Event

AESTDY

Study Day of Start of Adverse Event

AEENDY

Study Day of End of Adverse Event

ASTDTM

Analysis Start Date/Time

ASTDTF

Analysis Start Date Imputation Flag

ASTTMF

Analysis Start Time Imputation Flag

AENDTM

Analysis End Date/Time

AENDTF

Analysis End Date Imputation Flag

AENTMF

Analysis End Time Imputation Flag

ASTDT

Analysis Start Date

AENDT

Analysis End Date

ASTDY

Analysis Start Relative Day

AENDY

Analysis End Relative Day

ADURN

Analysis Duration (N)

ADURU

Analysis Duration Units

LDOSEDTM

End Date/Time of Last Dose

ASEV

Analysis Severity/Intensity

AREL

Analysis Causality

TRTEMFL

Treatment Emergent Analysis Flag

ASEVN

Analysis Severity/Intensity (N)

AOCCIFL

1st Max Sev./Int. Occurrence Flag

AETOXGR

Standard Toxicity Grade

AETOXGRN

Standard Toxicity Grade (N)

AEACN_DECODE

Action Taken with Study Treatment

DOSEDY

Day of Study Drug

DOSEU

Treatment Dose Units

DOSEON

Treatment Dose at Record Start

AECONTRT

Concomitant or Additional Trtmnt Given

CQ01NAM

Customized Query 01 Name

CQ02NAM

Customized Query 02 Name

CQ03NAM

Customized Query 03 Name

AESMIE

Other Medically Important Serious Event

ACAT1

Analysis Category 1

AESER_DECODE

Serious Event

AEREL_DECODE

Causality

AEOUT_DECODE

Outcome of Adverse Event

AOCCFL

1st Occurance within Subject Flag

AOCCPFL

1st Occurance within Preferred Term Flag

AOCCSFL

1st Occurrence of SOC Flag

TRT01A

Actual Treatment for Period 01

SAFFL

Safety Population Flag

AGE

Age

SEX

Sex

RACE

Race

RACE_DECODE

Race

STUDYID

Study Identifier

AGEGR1

Pooled Age Group 1

FMQNAM

FMQNAM

FMQSOC

FMQSOC

FMQCLASS

FMQCLASS

Source

data from adae from pharmaverseadam and, FDA_FMW_Consolidated_List.rds and FDA_FMQ_References.rds

See Also

adae adaefmq adcm adeg adex adexsum adlb adsl adttesaf advs# nolint

Examples

 head(data("adaefmq"))

adcm

Description

adcm modified from pharmaverseadam

Usage

adcm

Format

A data frame with 7276 rows and 62 variables:

DOMAIN

Domain Abbreviation

USUBJID

Unique Subject Identifier

CMSEQ

Sequence Number

CMSPID

Sponsor-Defined Identifier

CMTRT

Reported Name of Drug, Med, or Therapy

CMDECOD

Standardized Medication Name

CMINDC

Indication

CMCLAS

Medication Class

CMDOSE

Dose per Administration

CMDOSU

Dose Units

CMDOSFRQ

Dosing Frequency per Interval

CMROUTE

Route of Administration

VISITNUM

Visit Number

VISIT

Visit Name

VISITDY

Planned Study Day of Visit

CMDTC

Date/Time of Collection

CMSTDTC

Start Date/Time of Medication

CMENDTC

End Date/Time of Medication

CMSTDY

Study Day of Start of Medication

CMENDY

Study Day of End of Medication

CMENRTPT

End Relative to Reference Time Point

ASTDTM

Analysis Start Date/Time

ASTDTF

Analysis Start Date Imputation Flag

ASTTMF

Analysis Start Time Imputation Flag

AENDTM

Analysis End Date/Time

AENDTF

Analysis End Date Imputation Flag

AENTMF

Analysis End Time Imputation Flag

ASTDT

Analysis Start Date

AENDT

Analysis End Date

ASTDY

Analysis Start Relative Day

AENDY

Analysis End Relative Day

ADURN

Analysis Duration (N)

ADURU

Analysis Duration Units

ONTRTFL

On Treatment Record Flag

PREFL

Pre-treatment Flag

FUPFL

Follow-up Flag

ANL01FL

Analysis Flag 01

AOCCPFL

1st Occurrence of Preferred Term Flag

APHASE

Phase

APHASEN

Description of Phase N

TRTP

Planned Treatment

TRTA

Actual Treatment

CMLVL1

Preferred ATC Text for ATC Level 1

CMLVL2

Preferred ATC Text for ATC Level 2

CMLVL3

Preferred ATC Text for ATC Level 3

CMLVL4

Preferred ATC Text for ATC Level 4

CMBASPRF

Base Preferred Term

CMPRESP

CM Pre-specified

CMOCCUR

CM Occurrence

CMINDCSP

Indication Specification

CMDOSTXT

Dose Description

CMENRF

End Relative to Reference Period

CQ01NAM

Customized Query 01 Name

CQ02NAM

Customized Query 02 Name

CQ03NAM

Customized Query 03 Name

CQ04NAM

Customized Query 04 Name

CQ05NAM

Customized Query 05 Name

CQ06NAM

Customized Query 06 Name

CQ07NAM

Customized Query 07 Name

TRT01A

Actual Treatment for Period 01

SAFFL

Safety Population Flag

TRTSDT

Date of First Exposure to Treatment

Source

data from pharmaverseadam.

See Also

adae adaefmq adcm adeg adex adexsum adlb adsl adttesaf advs# nolint

Examples

 head(data("adcm"))

adeg

Description

adeg modified from pharmaverseadam

Usage

adeg

Format

A data frame with 11844 rows and 70 variables:

DOMAIN

Domain Abbreviation

USUBJID

Unique Subject Identifier

EGSEQ

Sequence Number

EGTESTCD

ECG Test or Examination Short Name

EGTEST

ECG Test or Examination Name

EGORRES

Result or Finding in Original Units

EGORRESU

Original Units

EGSTRESC

Character Result/Finding in Std Format

EGSTRESN

Numeric Result/Finding in Standard Units

EGSTRESU

Standard Units

EGSTAT

Completion Status

EGLOC

Lead Location Used for Measurement

EGBLFL

Baseline Flag

VISITNUM

Visit Number

VISIT

Visit Name

VISITDY

Planned Study Day of Visit

EGDTC

Date/Time of ECG

EGDY

Study Day of ECG

EGTPT

Planned Time Point Name

EGTPTNUM

Planned Time Point Number

EGELTM

Planned Elapsed Time from Time Point Ref

EGTPTREF

Time Point Reference

ADTM

Analysis Datetime

ATMF

Analysis Time Imputation Flag

ADY

Analysis Relative Day

PARAMCD

Parameter Code

AVAL

Analysis Value

AVALC

Analysis Value (C)

ADT

Analysis Date

ATPTN

Analysis Timepoint (N)

ATPT

Analysis Timepoint

AVISIT

Analysis Visit

AVISITN

Analysis Visit (N)

DTYPE

Derivation Type

ONTRTFL

On Treatment Record Flag

ANRLO

Analysis Normal Range Lower Limit

ANRHI

Analysis Normal Range Upper Limit

ANRIND

Analysis Reference Range Indicator

BASETYPE

Baseline Type

ABLFL

Baseline Record Flag

BASEC

Baseline Value (C)

CHG

Change from Baseline

PCHG

Percent Change from Baseline

ANL01FL

Analysis Flag 01-Analysis Value

TRTP

Planned Treatment

TRTA

Actual Treatment

ASEQ

Analysis Sequence Number

AVALCAT1

Analysis Value Category 1

AVALCA1N

Analysis Value Category 1 (N)

CHGCAT1

Change from Baseline Category 1

CHGCAT1N

Change from Baseline Category 1 (N)

PARAM

Parameter

PARAMN

Parameter (N)

TRTEMFL

Treatment Emergent Analysis Flag

ANL02FL

Analysis Flag 02-By Visit Value

ANL03FL

Analysis Flag 03-Maximum Value

APOBLFL

Post-Baseline Record Flag

CRIT1

Analysis Criterion 1

CRIT1FL

Criterion 1 Evaluation Result Flag

CRIT2

Analysis Criterion 2

CRIT2FL

Criterion 2 Evaluation Result Flag

BASE

Baseline Value

BNRIND

Baseline Reference Range Indicator

BASECAT1

Baseline Category 1

TRT01A

Actual Treatment for Period 01

SAFFL

Safety Population Flag

STUDYID

Study Identifier

AGE

Age

SEX

Sex

RACE_DECODE

Race

Source

data from pharmaverseadam.

See Also

adae adaefmq adcm adeg adex adexsum adlb adsl adttesaf advs# nolint

Examples

 head(data("adeg"))

adex

Description

adex modified from pharmaverseadam

Usage

adex

Format

A data frame with 591 rows and 128 variables:

STUDYID

Study Identifier

DOMAIN

Domain Abbreviation

USUBJID

Unique Subject Identifier

EXSEQ

Sequence Number

EXTRT

Planned Treatment

EXDOSE

Adjusted Dose

EXDOSU

Dose Units

EXDOSFRM

Dose Form

EXDOSFRQ

Dosing Frequency per Interval

EXROUTE

Route of Administration

VISITNUM

Visit Number

VISIT

Visit Name

VISITDY

Planned Study Day of Visit

EXSTDTC

Start Date/Time of Treatment

EXENDTC

End Date/Time of Treatment

EXSTDY

Study Day of Start of Treatment

EXENDY

Study Day of End of Treatment

EXADJ

Reason for Dose Adjustment

EXPLDOS

Planned Dose

TRTSDT

Date of First Exposure to Treatment

TRTSDTM

Datetime of First Exposure to Treatment

TRTEDTM

Datetime of Last Exposure to Treatment

ASTDTM

Analysis Start Datetime

ASTDTF

Analysis Start Date Imputation Flag

ASTTMF

Analysis Start Time Imputation Flag

AENDTM

Analysis End Datetime

AENDTF

Analysis End Date Imputation Flag

AENTMF

Analysis End Time Imputation Flag

ASTDY

Analysis Start Relative Day

AENDY

Analysis End Relative Day

EXDURD

Duration of Treatment (Days)

ASTDT

Analysis Start Date

AENDT

Analysis End Date

DOSEO

Dose O

PDOSEO

PDose O

PARAMCD

Parameter Code

AVAL

Analysis Value

AVALC

Analysis Value (C)

PARCAT1

Parameter Category 1

PARAM

Parameter

PARAMN

Parameter (N)

AVALCAT1

Analysis Value Category 1

ASEQ

Analysis Sequence Number

SUBJID

Subject Identifier for the Study

RFSTDTC

Subject Reference Start Date/Time

RFENDTC

Subject Reference End Date/Time

RFXSTDTC

Date/Time of First Study Treatment

RFXENDTC

Date/Time of Last Study Treatment

RFICDTC

Date/Time of Informed Consent

RFPENDTC

Date/Time of End of Participation

DTHDTC

Date/Time of Death

DTHFL

Subject Death Flag

SITEID

Study Site Identifier

AGE

Age

AGEU

Age Units

SEX

Sex

RACE

Race

ETHNIC

Ethnicity

ARMCD

Treatment Category Code

ARM

Treatment Group

ACTARMCD

Actual Arm Code

ACTARM

Actual Treatment Group

COUNTRY

Country

DMDTC

Date/Time of Collection

DMDY

Study Day of Collection

TRT01P

Planned Treatment for Period 01

TRT01A

Actual Treatment for Period 01

TRTSTMF

Time of First Exposure Imput. Flag

TRTETMF

Time of Last Exposure Imput. Flag

TRTEDT

Date of Last Exposure to Treatment

TRTDURD

Total Treatment Duration (Days)

SCRFDT

Screen Failure Date

EOSDT

End of Study Date

EOSSTT

End of Study Status

FRVDT

Final Retrievel Visit Date

RANDDT

Date of Randomization

DTHDT

Date of Death

DTHDTF

DTHDTF

DTHADY

Relative Day of Death

LDDTHELD

Elapsed Days from Last Dose to Death

DTHCAUS

DTHCAUS

DTHDOM

DTHDOM

DTHCGR1

DTHCGR1

LSTALVDT

Date Last Known Alive

SAFFL

Safety Population Flag

RACEGR1

Pooled Race Group 1

AGEGR1

Age Group

REGION1

Geographic Region 1

LDDTHGR1

Last Dose to Death - Days Elapsed Grp 1

DTH30FL

Death Within 30 Days of Last Trt Flag

DTHA30FL

Death After 30 Days from Last Trt Flag

DTHB30FL

Death Within 30 Days of First Trt Flag

ATRT

Analysis name of Treatment

DAEXPDTC

Date of Exposure

EXLOT

Lot Number

ADOSE

Analysis Dose

TRT01PN

Planned Treatment for Period 01 (N)

AVISITN

Visit Number

AVISIT

Visit Label

TRT01AN

Actual Treatment for Period 01 (N)

AOCCUR

Analysis Occurrence

RACE_DECODE

Race

ACAT1

Analysis Category 1

AREASOC

Analysis Reason for Occur Value

AREASOO

Other Analysis Reason for Occur Value

AADJ

Analysis Reason for Dose Adjustment

AADJPOTH

Other Anal Reason for Dose Adjust Prior

AADJP

Analysis Reason for Dose Adjustment Prior

AACTDU

Analysis Action Taken During Study Trt

AACTDU1

Act Takn Dur Infus-Full Dose Admined

AACTDU2

Act Takn Dur Infus-Infusion Aborted

AACTDU3

Act Takn Dur Infus-Infusion Interrupted

AACTDU4

Act Takn Dur Infus-Infusion Rate Decrsed

AACTDU5

Act Takn Dur Infus-Infusion Rate Incrsed

AADJOTH

Other Anal Reason for Dose Adjustment

ACAT2

Analysis Category 2

AACTPR

Action Taken Prior to Infudion Start

AACTPR_DECODE

Action Taken Prior to Infusion Start

ASCHDOSE

Analysis Scheduled Dose

ASCHDOSU

Analysis Scheduled Dose Units

ADOSFRM

Analysis Dose Form

ADOSU

Analysis Dose Units

ADOSFRQ

Analysis Dosing Frequency per Interval

AROUTE

Analysis Route of Administration

ATVINF

Analysis Total Volume Infused

ATVINFU

Analysis Total Volume Infused Units

AINFRAT

Analysis Infusion Rate

AINFRAU

Analysis Infusion Rate Unit

Source

data from pharmaverseadam.

See Also

adae adaefmq adcm adeg adex adexsum adlb adsl adttesaf advs# nolint

Examples

 head(data("adex"))

adexsum

Description

adex modified from pharmaverseadam

Usage

adexsum

Format

A data frame with 2794 rows and 25 variables:

USUBJID

Unique Subject Identifier

PARAMCD

Parameter Code

PARAM

Parameter

AVAL

Analysis Value

AVALCAT1

Analysis Value Category 1

AVALCA1N

Analysis Value Category 1 (N)

CRIT1

Analysis Criterion 1

CRIT1FL

Criterion 1 Evaluation Result Flag

CRIT2

Analysis Criterion 2

CRIT2FL

Criterion 2 Evaluation Result Flag

CRIT3

Analysis Criterion 3

CRIT3FL

Criterion 3 Evaluation Result Flag

CRIT4

Analysis Criterion 4

CRIT4FL

Criterion 4 Evaluation Result Flag

CRIT5

Analysis Criterion 5

CRIT5FL

Criterion 5 Evaluation Result Flag

CRIT6

Analysis Criterion 6

CRIT6FL

Criterion 6 Evaluation Result Flag

CRIT7

Analysis Criterion 7

CRIT7FL

Criterion 7 Evaluation Result Flag

AVISIT

Analysis Visit

AVISITN

Analysis Visit (N)

TRT01A

Actual Treatment for Period 01

SAFFL

Safety Population Flag

STUDYID

Study Identifier

Source

data from adex from pharmaverseadam

See Also

adae adaefmq adcm adeg adex adexsum adlb adsl adttesaf advs# nolint

Examples

 head(data("adexsum"))

adlb

Description

adlb modified from pharmaverseadam

Usage

adlb

Format

A data frame with 83640 rows and 152 variables:

STUDYID

Study Identifier

DOMAIN

Domain Abbreviation

USUBJID

Unique Subject Identifier

LBSEQ

Sequence Number

LBTESTCD

Lab Test or Examination Short Name

LBTEST

Lab Test or Examination Name

LBCAT

Category for Lab Test

LBORRES

Result or Finding in Original Units

LBORRESU

Original Units

LBORNRLO

Reference Range Lower Limit in Orig Unit

LBORNRHI

Reference Range Upper Limit in Orig Unit

LBSTRESC

Character Result/Finding in Std Format

LBSTRESN

Numeric Result/Finding in Standard Units

LBSTRESU

Standard Units

LBSTNRLO

Reference Range Lower Limit-Std Units

LBSTNRHI

Reference Range Upper Limit-Std Units

LBNRIND

Reference Range Indicator

LBBLFL

Baseline Flag

VISITNUM

Visit Number

VISIT

Visit Name

VISITDY

Planned Study Day of Visit

LBDTC

Date/Time of Specimen Collection

LBDY

Study Day of Specimen Collection

TRTSDT

Date of First Exposure to Treatment

TRTEDT

Date of Last Exposure to Treatment

TRT01A

Actual Treatment for Period 01

TRT01P

Planned Treatment for Period 01

ADT

Analysis Date

ADY

Analysis Relative Day

PARAMCD

Parameter Code

PARAM

Parameter

PARAMN

Parameter (N)

PARCAT1

Parameter Category 1

AVAL

Analysis Value

AVALC

Analysis Value (C)

ANRLO

Analysis Normal Range Lower Limit

ANRHI

Analysis Normal Range Upper Limit

DTYPE

Derivation Type

AVISIT

Analysis Visit

AVISITN

Analysis Visit (N)

ONTRTFL

On Treatment Record Flag

ANRIND

Analysis Reference Range Indicator

BASETYPE

Baseline Type

ABLFL

Baseline Record Flag

BASE

Baseline Value

BASEC

Baseline Value (C)

BNRIND

Baseline Reference Range Indicator

CHG

Change from Baseline

PCHG

Percent Change from Baseline

ATOXDSCL

Analysis Toxicity Description Low

ATOXDSCH

Analysis Toxicity Description High

ATOXGRL

Analysis Toxicity Grade Low

ATOXGRH

Analysis Toxicity Grade High

ATOXGR

Analysis Toxicity Grade

BTOXGRL

Baseline Toxicity Grade Low

BTOXGRH

Baseline Toxicity Grade High

BTOXGR

Baseline Toxicity Grade

R2BASE

Ratio to Baseline

R2ANRLO

Ratio of Analysis Val compared to ANRLO

R2ANRHI

Ratio of Analysis Val compared to ANRHI

SHIFT1

Shift from Baseline to Analysis Value

SHIFT2

Shift from Baseline to Overall Grade

ANL01FL

Analysis Flag 01

LVOTFL

Last Value On Treatment Record Flag

TRTP

Planned Treatment

TRTA

Actual Treatment

ASEQ

Analysis Sequence Number

SUBJID

Subject Identifier for the Study

RFSTDTC

Subject Reference Start Date/Time

RFENDTC

Subject Reference End Date/Time

RFXSTDTC

Date/Time of First Study Treatment

RFXENDTC

Date/Time of Last Study Treatment

RFICDTC

Date/Time of Informed Consent

RFPENDTC

Date/Time of End of Participation

DTHDTC

Date/Time of Death

DTHFL

Subject Death Flag

SITEID

Study Site Identifier

AGE

Age

AGEU

Age Units

SEX

Sex

RACE

Race

ETHNIC

Ethnicity

ARMCD

Planned Arm Code

ARM

Description of Planned Arm

ACTARMCD

Actual Arm Code

ACTARM

Description of Actual Arm

COUNTRY

Country

DMDTC

Date/Time of Collection

DMDY

Study Day of Collection

TRTSDTM

Datetime of First Exposure to Treatment

TRTSTMF

Time of First Exposure Imput. Flag

TRTEDTM

Datetime of Last Exposure to Treatment

TRTETMF

Time of Last Exposure Imput. Flag

TRTDURD

Total Treatment Duration (Days)

SCRFDT

Screen Failure Date

EOSDT

End of Study Date

EOSSTT

End of Study Status

FRVDT

Final Retrievel Visit Date

RANDDT

Date of Randomization

DTHDT

Date of Death

DTHDTF

DTHDTF

DTHADY

Relative Day of Death

LDDTHELD

Elapsed Days from Last Dose to Death

DTHCAUS

DTHCAUS

DTHDOM

DTHDOM

DTHCGR1

DTHCGR1

LSTALVDT

Date Last Known Alive

SAFFL

Safety Population Flag

RACEGR1

Pooled Race Group 1

REGION1

Geographic Region 1

LDDTHGR1

Last Dose to Death - Days Elapsed Grp 1

DTH30FL

Death Within 30 Days of Last Trt Flag

DTHA30FL

Death After 30 Days from Last Trt Flag

DTHB30FL

Death Within 30 Days of First Trt Flag

TRT01PN

Planned Treatment for Period 01 (N)

TRT01AN

Actual Treatment for Period 01 (N)

AVALU

Analysis Value - Units

ANL02FL

Analysis Record Flag 02-Analysis Value

TRTEMFL

Treatment Emergent Analysis Flag

COUNTRY_DECODE

Country

RACE_DECODE

Race Description

ETHNIC_DECODE

Ethnicity Description

PARCAT2

Parameter Category 2

PARCAT3

Parameter Category 3

PARCAT4

Parameter Category 4

PARCAT5

Parameter Category 5

PARCAT6

Parameter Category 6

MCRIT2ML

Multi-Response Criterion 2 Evaluation

MCRIT1ML

Multi-Response Criterion 1 Evaluation

MCRIT1MN

Multi-Response Criterion 1 Eval (N)

MCRIT2MN

Multi-Response Criterion 2 Eval (N)

MCRIT1

Analysis Multi-Response Criterion 1

MCRIT2

Analysis Multi-Response Criterion 2

APOBLFL

Post-Baseline Record Flag

LBSTNRHQ

Reference Limit Higher

LBSTNRLQ

Reference Limit Lower

ATOXGRN

Analysis Toxicity Grade (Numeric)

ADTM

Analysis Date/Time

ATPT

Analysis Timepoint

TR01SDT

Start Date of Treatment for Period 01

TR01EDT

End Date of Treatment for Period 01

ANL03FL

Analysis Record Flag 03 - Protocol Visit

ANL04FL

Analysis Flag 04

ANL05FL

Analysis Flag 05

ANL06FL

Analysis Flag 06

ANL07FL

Analysis Flag 07

ANL08FL

Analysis Flag 08

ANL09FL

Analysis Flag 09

ANL10FL

Analysis Flag 10

ANL14FL

Analysis Flag 14

ANL15FL

Analysis Flag 15

ANL16FL

Analysis Flag 16

Source

data from pharmaverseadam.

See Also

adae adaefmq adcm adeg adex adexsum adlb adsl adttesaf advs# nolint

Examples

 head(data("adlb"))

adsl

Description

adsl modified from pharmaverseadam

Usage

adsl

Format

A data frame with 306 rows and 106 variables:

STUDYID

Study Identifier

USUBJID

Unique Subject Identifier

SUBJID

Subject Identifier for the Study

RFSTDTC

Subject Reference Start Date/Time

RFENDTC

Subject Reference End Date/Time

RFXSTDTC

Date/Time of First Study Treatment

RFXENDTC

Date/Time of Last Study Treatment

RFICDTC

Date/Time of Informed Consent

RFPENDTC

Date/Time of End of Participation

DTHDTC

Date/Time of Death

DTHFL

Subject Death Flag

SITEID

Study Site Identifier

AGE

Age

AGEU

Age Units

SEX

Sex

RACE

Race

ETHNIC

Ethnicity

ARMCD

Planned Arm Code

ARM

Description of Planned Arm

ACTARMCD

Actual Arm Code

ACTARM

Description of Actual Arm

COUNTRY

Country

DMDTC

Date/Time of Collection

DMDY

Study Day of Collection

TRT01P

Planned Treatment for Period 01

TRT01A

Actual Treatment for Period 01

TRTSDTM

Datetime of First Exposure to Treatment

TRTSTMF

Time of First Exposure Imput. Flag

TRTEDTM

Datetime of Last Exposure to Treatment

TRTETMF

Time of Last Exposure Imput. Flag

TRTSDT

Date of First Exposure to Treatment

TRTEDT

Date of Last Exposure to Treatment

TRTDURD

Total Treatment Duration (Days)

SCRFDT

Screen Failure Date

EOSDT

End of Study Date

EOSSTT

End of Study Status

FRVDT

Final Retrievel Visit Date

RANDDT

Date of Randomization

DTHDT

Date of Death

DTHDTF

Date of Death Imputation Flag

DTHADY

Relative Day of Death

LDDTHELD

Elapsed Days from Last Dose to Death

DTHCAUS

DTHCAUS

DTHDOM

DTHDOM

DTHCGR1

DTHCGR1

LSTALVDT

Date Last Known Alive

SAFFL

Safety Population Flag

RACEGR1

Pooled Race Group 1

AGEGR1

Pooled Age Group 1

REGION1

Geographic Region 1

LDDTHGR1

Last Dose to Death - Days Elapsed Grp 1

DTH30FL

Death Within 30 Days of Last Trt Flag

DTHA30FL

Death After 30 Days from Last Trt Flag

DTHB30FL

Death Within 30 Days of First Trt Flag

TRT01PN

Planned Treatment for Period 01 (N)

TRT01AN

Actual Treatment for Period 01 (N)

AGEGR1N

Pooled Age Group 1 (N)

SEX_DECODE

Sex

WEIGHTBL

Weight (kg)

WGTGR1N

Weight Group 1 (N)

WGTGR1

Weight Group 1

HEIGHTBL

Height (cm)

BSABL

Body surface area (m2)

BMIBL

Body mass index (kg/m2)

BMIBLG1N

BMI at Baseline Group 1 (N)

BMIBLG1

BMI at Baseline Group 1

COUNTRY_DECODE

Country

RACE_DECODE

Race

RFICDT

Date of Informed Consent

ETHNIC_DECODE

Ethnicity

STRAT1R

Strat Factor 1 Value Used for Rand

STRAT2R

Strat Factor 2 Value Used for Rand

RANUM

Randomization Number

RANDDTM

Datetime of Randomization

EOTSTT

End of Treatment Status

DCTREAS

Reason for Discontinuation of Treatment

LTVISIT

Last Treatment Visit

DCTREASP

Reason Specify for Discont of Treatment

DCTDT

End of Study Date

DCSREAS

Reason for Discontinuation from Study

DCSREASP

Reason Spec for Discont from Study

LSVISIT

Last Study Visit

TRTEDY

Treatment Relative End Day

SCRNFL

Screened Population Flag

SCRFFL

Screen Failure Flag

DCSCREEN

Reason for Discont During Screening

ENRLFL

Enrolled Population Flag

RANDFL

Randomized Flag

ITTFL

Intent-To-Treat Population Flag

FASFL

Full Analysis Set Population Flag

PPROTFL

Per-Protocol Population Flag

LSTSVDT

Last Subject Visit (SV) Date

EOSDY

Study Day of Study Termination

UNBLNDFL

Subject Blind Broken

RESCRNFL

Re-screened Flag

DTHTRTFL

Death on Treatment Flag

DTHCAUSP

Cause Spec for Death

DTHAFTFL

Death After 30 Days of Last Treatment

DTH60TFL

Death Within 60 Days of First Treatment

UNBLNDDY

Study Day of Unblinding

UNBREAS

Reason For Unblinding

LDOSE

Last Dose

LDOSU

Last Dose Unit

DTHTERM

Reported Cause of Death

LDSTODTH

Days from Last Dose to Death

DTHDY

Study Day of Death

Source

data from pharmaverseadam.

See Also

adae adaefmq adcm adeg adex adexsum adlb adsl adttesaf advs# nolint

Examples

 head(data("adsl"))

adttesaf

Description

adtte_onc modified from pharmaverseadam

Usage

adttesaf

Format

A data frame with 2032 rows and 9 variables:

USUBJID

Unique Subject Identifier

PARAMCD

Parameter Code

PARAM

Parameter

AVAL

Analysis Value

CNSR

Censor

STARTDT

Start Date

ADT

Analysis Date

TRT01A

Actual Treatment for Period 01

SAFFL

Safety Population Flag

Source

data from adtte_onc from pharmaverseadam

See Also

adae adaefmq adcm adeg adex adexsum adlb adsl adttesaf advs# nolint

Examples

 head(data("adttesaf"))

advs

Description

advs modified from pharmaverseadam

Usage

advs

Format

A data frame with 40702 rows and 78 variables:

DOMAIN

Domain Abbreviation

USUBJID

Unique Subject Identifier

VSSEQ

Sequence Number

VSTESTCD

Vital Signs Test Short Name

VSTEST

Vital Signs Test Name

VSPOS

Vital Signs Position of Subject

VSORRES

Result or Finding in Original Units

VSORRESU

Original Units

VSSTRESC

Character Result/Finding in Std Format

VSSTRESN

Numeric Result/Finding in Standard Units

VSSTRESU

Standard Units

VSSTAT

Completion Status

VSLOC

Location of Vital Signs Measurement

VSBLFL

Baseline Flag

VISITNUM

Visit Number

VISIT

Visit Name

VISITDY

Planned Study Day of Visit

VSDTC

Date/Time of Measurements

VSDY

Study Day of Vital Signs

VSTPT

Planned Time Point Name

VSTPTNUM

Planned Time Point Number

VSELTM

Planned Elapsed Time from Time Point Ref

VSTPTREF

Time Point Reference

ADT

Analysis Date

ADY

Analysis Relative Day

PARAMCD

Parameter Code

AVAL

Analysis Value

ATPTN

Analysis Timepoint (N)

ATPT

Analysis Time Point

AVISIT

Analysis Visit

AVISITN

Analysis Visit (N)

DTYPE

Derivation Type

ONTRTFL

On Treatment Record Flag

ANRLO

Analysis Normal Range Lower Limit

ANRHI

Analysis Normal Range Upper Limit

A1LO

Analysis Range 1 Lower Limit

A1HI

Analysis Range 1 Upper Limit

ANRIND

Analysis Reference Range Indicator

BASETYPE

Baseline Type

ABLFL

Baseline Record Flag

CHG

Change from Baseline

PCHG

Percent Change from Baseline

ANL01FL

Analysis Flag 01

TRTP

Planned Treatment

TRTA

Actual Treatment

ASEQ

Analysis Sequence Number

AVALCAT1

Analysis Value Category 1

AVALCA1N

Analysis Value Category 1 (N)

PARAM

Parameter

PARAMN

Parameter (N)

AVALC

Analysis Value (C)

ANL02FL

Analysis Flag 02-By Visit Value

APOBLFL

Post-Baseline Record Flag

BASE

Baseline Value

BNRIND

Baseline Reference Range Indicator

ADTM

Analysis Date/Time

CRIT1

Analysis Criterion 1

CRIT1FL

Criterion 1 Evaluation Result Flag

CRIT2

Analysis Criterion 2

CRIT2FL

Criterion 2 Evaluation Result Flag

CRIT3

Analysis Criterion 3

CRIT3FL

Criterion 3 Evaluation Result Flag

ATOXDSCL

Analysis Toxicity Description Low

ATOXDSCH

Analysis Toxicity Description High

ATOXGRL

Analysis Toxicity Grade Low

ATOXGRH

Analysis Toxicity Grade High

ATOXGR

Analysis Toxicity Grade

ANL06FL

Analysis Flag 06-Minimum Value

ANL05FL

Analysis Flag 05-Worst Tox Grade High

ANL04FL

Analysis Flag 04-Worst Value

ANL03FL

Analysis Flag 03-Maximum Value

TRTEMFL

Treatment Emergent Analysis Flag

TRT01A

Actual Treatment for Period 01

SAFFL

Safety Population Flag

STUDYID

Study Identifier

AGE

Age

SEX

Sex

RACE_DECODE

Race

Source

data from pharmaverseadam.

See Also

adae adaefmq adcm adeg adex adexsum adlb adsl adttesaf advs# nolint

Examples

 head(data("advs"))